Frank Pasqualone's most recent trade in Theravance Biopharma Inc was a trade of 3,779 Ordinary Shares done at an average price of $8.4 . Disclosure was reported to the exchange on Nov. 19, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Theravance Biopharma Inc | Frank Pasqualone | SVP, CHIEF BUSINESS OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.36 per share. | 19 Nov 2021 | 3,779 | 429,783 (0%) | 0% | 8.4 | 31,592 | Ordinary Shares |
| Theravance Biopharma Inc | Frank Pasqualone | SVP, Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.05 per share. | 20 Aug 2021 | 3,779 | 433,562 (0%) | 0% | 14.1 | 53,095 | Ordinary Shares |
| Theravance Biopharma Inc | Frank Pasqualone | SVP, Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.80 per share. | 20 May 2021 | 3,779 | 437,341 (0%) | 0% | 17.8 | 67,266 | Ordinary Shares |
| Theravance Biopharma Inc | Frank Pasqualone | SVP, Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.79 per share. | 20 Feb 2021 | 26,961 | 439,719 (0%) | 0% | 18.8 | 506,597 | Ordinary Shares |
| Theravance Biopharma Inc | Frank Pasqualone | SVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 65,000 | 466,680 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Frank Pasqualone | SVP, Chief Comm Ops Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.21 per share. | 20 Nov 2020 | 4,214 | 401,680 (0%) | 0% | 17.2 | 72,523 | Ordinary Shares |